Home LiteratureArticle Details
PMID: 10591201 Published · ppublish English Comment News

Alzheimer's disease. A firm base for drug development.

Nature ·Vol. 402 ·No. 6761 ·1999-12-02 ·Pages 471-2

De Strooper B, König G

Abstract

暂无摘要

MeSH Terms
Alzheimer Disease/drug therapy,enzymology Amyloid Precursor Protein Secretases Amyloid beta-Peptides/metabolism Aspartic Acid Endopeptidases/antagonists & inhibitors,isolation & purification,metabolism Endopeptidases Enzyme Inhibitors/pharmacology,therapeutic use Humans
Chemicals
Amyloid beta-Peptides Enzyme Inhibitors Amyloid Precursor Protein Secretases Endopeptidases Aspartic Acid Endopeptidases BACE2 protein, human BACE1 protein, human
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
De Strooper B
König G
Article Info
Journal
Nature
Abbr.
Nature
ISSN
0028-0836
DOI
10.1038/44973
Published
1999-12-02
Pages
471-2
Language
English
Region
England
NLM ID
0410462
Subset
IM
Corrections
CommentOn
PMID: 10591213
CommentOn
PMID: 10591214
External Links
PubMed source DOI: 10.1038/44973 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2